C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) C12N 15/19 (2006.01)
Patent
CA 2566299
This invention relates to a recombinant gene sequence that comprises human SLC gene, antigen gene, and IgG 1-Fc fragment gene, wherein the SLC gene is linked upstream to the antigen gene, and the IgG1-Fc fragment is linked downstream to the antigen gene. This invention also relates to the application of the recombinant gene sequence in the preparation of gene vaccine.
La présente invention concerne une séquence génique recombinante, qui comprend le gène humain SLC, le gène antigène et le gène du fragment Fc d'IgGI. Le gène SLC et le gène du fragment Fc sont liés en amont et en aval du gène antigène, respectivement. L'invention concerne également l'utilisation du gène recombinant dans la préparation d'un vaccin.
Fu Ming
Liang Xiao
Lin Chen
Ma Wenbo
Qin Hanjun
Cancer Institute Chinese Academy Of Medical Sciences
Dongguan Haofa Bio-Engineering Development Co. Ltd
Kirby Eades Gale Baker
LandOfFree
Recombinant chemotactic antigen gene vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant chemotactic antigen gene vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant chemotactic antigen gene vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1515026